Suraksha Diagnostic Ltd
NSE: SURAKSHA · Healthcare Service Provider · sector
₹312.65NSE close 2026-10-26
Key numbers
Market cap₹1,628 cr
Price₹312.65
52w high / low₹360 / ₹224
P/E45.4xSector median 22.9x
P/B6.7xSector median 2.0x
Book value₹47.0
Dividend yield–Sector median 0.55%
ROE15.7%Sector median 5.4%
ROCE25.2%Sector median 6.8%
OPM31.4%Sector median 15.9%
Debt / equity0.01xSector median 0.07x
EV/EBITDA15.7xSector median 17.2x
Interest cover4.6x
Current ratio1.05x
Sales growth 3y–Sector median +13.5%
Profit growth 3y–Sector median +26.9%
PEG5.60x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹26 cr vs borrowings ₹2 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 4.6x in the last 12 months.
- 0.10% of the promoters' shares are pledged (0.1% of all shares).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 9% of net profit in the last 12 months.
- No dividend in the last 2 financial years.
- Price ₹312.65 on 2026-10-26: -13.2% from the 52-week high, +39.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹410.55 · low ₹245.27
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| EBITDA | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 34.7% | 30.7% | 29.5% | 32.7% | 30.6% | 29.8% | 29.9% | 34.7% |
| Other income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net profit | 10 | 6 | 7 | 9 | 9 | 8 | 6 | 13 |
| EPS (₹) | 1.94 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
| Revenue YoY | +17.9% | +30.5% | +25.1% | +20.7% | ||||
| Profit YoY | -13.1% | +25.8% | -15.0% | +38.4% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY25 | FY26 | TTM |
|---|---|---|---|
| Revenue | 252 | 310 | 325 |
| EBITDA | 81 | 95 | 102 |
| Net profit | 32 | 32 | 36 |
| EPS (₹) | 5.97 | 6.18 | 6.88 |
| Revenue growth | +23.1% | +23.3% | |
| Profit growth | +1.2% | +8.1% | |
| Dividend / share (₹) | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | +23.3% |
| Net profit | – | – | +8.1% |
| EPS | – | – | – |
| Share price | – | – (2y) | -6.6% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 211 | 245 |
| Borrowings | 6 | 2 |
| Cash & equivalents | 20 | 26 |
| Total assets | 334 | 448 |
| Fixed assets | 147 | 194 |
| Capital work in progress | 10 | 35 |
| Investments | 1 | 0 |
| Receivables | 14 | 23 |
| Inventory | 8 | 8 |
| Payables | 14 | 21 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 63 | 82 |
| Cash from investing | -40 | -52 |
| Cash from financing | -24 | -29 |
| Capex | 42 | 67 |
| Free cash flow | 21 | 14 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 15.1% | 13.1% |
| ROCE % | 22.9% | 23.2% |
| Debtor days | 20 | 27 |
| Inventory days | 100 | 81 |
| Payable days | 169 | 209 |
| Cash conversion cycle (days) | -49 | -101 |
| Working capital days | 6 | 3 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 49.10% |
| FIIs | 13.97% |
| DIIs | 21.56% |
| of which Mutual funds | 20.16% |
| Public (non-institutions) | 15.37% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 48.78% | 48.78% | 48.88% | 48.98% | 49.00% | 49.10% | 49.10% | 49.10% |
| Promoter group | % |
|---|---|
| Ritu Mittal | 15.93% |
| Satish Kumar Verma | 10.84% |
| Sarla Kejriwal | 9.23% |
| Somnath Chatterjee | 5.10% |
| Tinni Investments Limited | 4.62% |
| Dneema Overseas Private Limited | 3.21% |
| Aparajita Chatterjee | 0.10% |
| Bipul Mittal | 0.04% |
| Bipul Mittal HUF | 0.03% |
| Tandra Chatterjee | 0.00% |
| Bholanath Chattopadhyay | 0.00% |
| Manjusri Chatterjee | 0.00% |
| Tathagata Chatterjee | 0.00% |
| Goutam Chattopodhyay | 0.00% |
| Raman Kejriwal | 0.00% |
| Public holders above 1% | % |
|---|---|
| Orbimed Asia II Mauritius Limited | 12.88% |
| Nippon Life India Trustee Ltd-a/c Nippon India PHA | 7.48% |
| Kotak Small CAP Fund | 6.99% |
| Aditya Birla SUN Life Trustee Private Limited A/C | 3.79% |
| Bandhan Balanced Advantage Fund | 1.09% |
60,792 shareholders. Pledged: 0.10% of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-15 | Dividend | Dividend - Re 0.50 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | SURAKSHA |
| BSE code | 544293 |
| ISIN | INE877V01027 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.